1AD adalta limited
Add to My Watchlist 0.00% ! 0.3¢

Ann: Quarterly Appendix 4C and Activities Report, page-2

  1. Iseki
    1,190 Posts.
    lightbulb Created with Sketch. 252
    clock Created with Sketch.
    15/10/21
    16:14
    Post #: 56834478
    Plenty of exciting things happening so I expect we can look forward to regular announcements in the upcoming quarters.

    - lung fibrosis moving to inhaler Phase 1 trial
    - kidney fibrosis
    - radio diagnostics
    - CAR-T preclinical

    should any one of these succeed to the phase 2 level we should see lots of potential partners wheeling their barrow to our door.
    1AD Price at posting: 8.6¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Access all the latest ASX news here
right-arrow Created with Sketch.
NEWS The Watchlist - Hear from ASX Leaders!
right-arrow Created with Sketch.
RC1 Redcastle Delivers Positive Scoping Study for Queen Alexandra
right-arrow Created with Sketch.
NEWS Lakes Commences Drilling at Wombat-5 Well, Victoria
right-arrow Created with Sketch.
NEWS Investor education equals superior returns
right-arrow Created with Sketch.
NEWS Bellevue Gold: FY26 guidance and annual Resource & Reserve statement
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $2.782M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
12 9763466 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 15470189 19
View Market Depth
Last trade - 16.21pm 04/08/2025 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.